bioequivalence

Lyvispah, Dissolvable Form of Baclofen, Now Available in US

Lyvispah ā€” a dissolvable granular formulation of baclofen ā€” is now commercially availableĀ in the U.S. for adults and adolescents, 12 and older, with spasticity associated with multiple sclerosis (MS) and other spinal cord disorders. In people with MS, the strawberry-flavored formulation is particularly suitable to ease flexor…

Bafiertam, Oral Relapsing MS Therapy, Arrives in US

Bafiertam (monomethyl fumarate), a bioequivalent of TecfideraĀ to treat relapsing forms of multiple sclerosis (MS), is now available to patients in the U.S. through a network of specialty pharmacies, Banner Life Sciences, the therapyā€™s developer, announced. Banner previously stated that Bafiertam would arrive on the market…

AXIM Obtains More Financing for Its Cannabinoid Therapies for MS and Bowel Diseases

AXIM BiotechnologiesĀ has secured an additional $4 million in institutional financing to advance clinical trials of itsĀ cannabinoid therapies forĀ multiple sclerosis (MS) andĀ irritable bowel syndrome. Some of the trials involve a chewing-gum therapy delivery system.Ā The financing will let the company continue developing a patented chewing-gum-delivered therapy for pain andĀ spasticity. AXIM…